Net profit of Shukra Pharmaceuticals rose 35.09% to Rs 5.39 crore in the quarter ended March 2025 as against Rs 3.99 crore during the previous quarter ended March 2024. Sales rose 21.97% to Rs 13.27 crore in the quarter ended March 2025 as against Rs 10.88 crore during the previous quarter ended March 2024.
For the full year,net profit declined 48.33% to Rs 9.58 crore in the year ended March 2025 as against Rs 18.54 crore during the previous year ended March 2024. Sales declined 56.30% to Rs 32.59 crore in the year ended March 2025 as against Rs 74.57 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 13.27 | 10.88 | 22 | 32.59 | 74.57 | -56 |
| OPM % | 55.09 | 40.81 | - | 39.03 | 26.02 | - |
| PBDT | 8.51 | 5.75 | 48 | 16.34 | 21.93 | -25 |
| PBT | 7.57 | 5.23 | 45 | 13.34 | 19.88 | -33 |
| NP | 5.39 | 3.99 | 35 | 9.58 | 18.54 | -48 |